BioArctic AB logo

BIOA B - BioArctic AB Share Price

SEK63.5 0.2  0.3%

Last Trade - 20/09/19

Market Cap £462.1m
Enterprise Value £363.9m
Revenue £69.8m
Position in Universe 392nd / 1468
Bullish
Bearish
Unlock BIOA B Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BIOA B Revenue Unlock BIOA B Revenue

Net Income

BIOA B Net Income Unlock BIOA B Revenue

Normalised EPS

BIOA B Normalised EPS Unlock BIOA B Revenue

PE Ratio Range

BIOA B PE Ratio Range Unlock BIOA B Revenue

Dividend Yield Range

BIOA B Dividend Yield Range Unlock BIOA B Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BIOA B EPS Forecasts Unlock BIOA B Revenue
Profile Summary

BioArctic AB is a Sweden-based company engaged in the biotechnology sector. The Company focuses on the research and development of treatments, which aim at diseases that affect the central nervous system (CNS). Its therapeutic areas encompass neurodegenerative disorders, Alzheimer's disease, Parkinson's disease, complete spinal cord injury, as well as other CNS disorders. The Company owns a technology platform, which develops a range of therapeutic monoclonal antibodies. The Company's pipeline includes product candidates in various clinical phases, such as BAN2401, AE1501, BAN0805, imaging and biochemical biomarkers, BBB-technology and SC0806. The Company also operates through SpineMedical AB.

Directors
Last Annual December 31st, 2018
Last Interim June 30th, 2019
No. of Shareholders: n/a
No. of Employees: 39
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange OMX Nordic Exchange Stockholm
Shares in Issue 88,059,985
Free Float (0.0%)
Eligible for
ISAs
SIPPs
Address Warfvinges vag 35, STOCKHOLM, 112 51, Sweden
Web https://www.bioarctic.se/
Phone +46 8 6956930
Contact ()
Auditors Grant Thornton Sweden AB
BIOA B Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BIOA B
Upcoming Events for BIOA B
Similar to BIOA B
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.